2021 JCA-AACR Precision Cancer Medicine International Conference

Disclosure of Conflict of Interest (Required)

At JCA Meetings/Conferences, the lead presenter and the responsible researcher, their
spouse, family related in the first degree, or people who share income/property with them
must declare and disclose their COIs (the “responsible researcher” in general denotes
persons such as the Principle Investigator of the research laboratory or the Corresponding
Author in the case of submission of an original research paper to a journal). In accordance
with “JCA Conflict of Interest Policy in Cancer Research” , please disclose COIs. JCA may
penalize the presenters in the event of failure to disclose COI, in accordance with its
disciplinary code.

Standards of Declaration and Disclosure

  1. Existence or otherwise of position as an officer of or an advisor (including consultant, etc.)
    to companies or for-profit organizations (hereinafter the “Companies, etc.” )
    shall be declared if the annual value of remuneration from a single Company etc.
    is 1 million yen or more. If any of the declarer’ s Relatives, etc. is an employee of the
    Companies, etc., this shall also be declared.
  2. Ownership of equities (such as shares and stock options) and profit obtained from
    those equities shall be declared if the annual value of profit on shares of a single Company, etc.
    (total sum of dividends and proceeds from the sale of shares) is 1 million yen or more,
    or the proportion of shares owned in the Company, etc. is 5% or more.
    Ownership of stock options and so on shall be declared if latent profit from them is
    1 million yen or more.
  3. Patent royalties or transfer gains by the Companies, etc. shall be declared if the
    annual total value received from a single Company, etc. is 1 million yen or more.
  4. Lecture fees, honoraria, or other fees paid by the Companies, etc. for the time or labor
    of a researcher engaged for conference attendance (as a lecturer, chairperson, ad hoc advisor, etc.)
    shall be declared if the annual total value received from a single Company, etc.
    is 500,000 yen or more.
  5. Manuscript fees paid by the Companies etc. for the writing of pamphlets, etc. shall be declared
    if the annual total value received from a single Company, etc. is 500,000 yen or more.
  6. Research funds (such as contracted research funds, joint research funds, and clinical trial funds)
    provided under contract by the Companies, etc. or by non-profit organizations funded by the Companies, etc.
    shall be declared if annual total amounts of direct cost paid from a single Company, etc.
    or organization to the declarer is 1 million yen or more.
    If the declarer personally receives any consideration from the Companies, etc.,
    it shall be declared separately.
  7. Scholarship (incentive) endowments from the Companies, etc.
    or research grants provided from a private academic support organization shall be declared
    if a total of 1 million yen or more per year is allocated as direct cost from such funds from a single Company, etc.
    or organization to an individual declarer or the department (lecture/area of specialization etc.)
    or research facility an individual declarer belongs to,
    with substantial control over its use given to that individual.
  8. An endowed chair etc. funded by the Companies, etc. shall be declared if the declarer is affiliated with the chair.
    A researcher, etc. sent or provided by the Companies, etc.
    shall be declared if the declarer is the representative of the research facility with which
    the researcher, etc. is affiliated, regardless of whether or not employment costs for the researcher, etc.
    have been accepted.
  9. Any other remuneration (travel expenses, gifts, etc., that are not directly related to research)
    shall be declared if the annual value of such remuneration received from a single Company, etc.
    is 50,000 yen or more.

How to disclose your COI

  • Oral presentation: If there is any COI, the oral presenter should use the disclosure slide to present COI after the title slide,
    in order to clarify the names of companies and/or associations in question. If there is no COI,
    the presenter should indicate ‘I/We have no financial relationships to disclose.' as such on the sample slide.
  • Poster presentation: If there is any COI, the poster presenter should disclose the names of companies and/
    or associations in question at the bottom area of the poster.
    If there is no COI, the presenter should indicate ‘I/We have no financial relationships to disclose.’ as such on the sample slide.

(Officers/employees of companies)

Please indicate the name of the company in the presentation documents.
You do not need to disclose COI (however, if there is any COI with companies other than your own company, please declare it).

COI disclosure slide samples

If the lead presenter is the responsible researcher, choose the sample slide 1. If the leadpresenter is NOT the responsible researcher,
choose the sample slide 2 and prepare each COI disclosure slide on behalf of the responsible researcher.

  1. Lead presenter is the responsible researcher

    COI_sample_1.pptx

  2. Lead presenter is NOT the responsible researcher

    COI_sample_2.pptx

For inquiries concerning COI
Japanese Cancer Association Executive Office

COI declaration and disclosure

http://www.jca.gr.jp/english/coi.html